Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

被引:1
|
作者
Lin, Ziwei [1 ]
Si, Si [1 ]
Liu, Jia [2 ]
Zhu, Hao [1 ]
Xu, Jiawei [1 ]
Artime, Esther [3 ]
Khare, Swarna [4 ]
Higgins, Victoria [5 ]
Leith, Andrea [5 ]
Qu, Shen [2 ,6 ]
机构
[1] Eli Lilly & Co, Suzhou, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Endocrinol & Metab Ctr, Sch Med, Shanghai, Peoples R China
[3] Eli Lilly & Co, Alcobendas, Spain
[4] Eli Lilly & Co, Bracknell, England
[5] Adelphi Real World, Bollington, England
[6] SinoUnited Hlth, Endocrinol Metab & Thyroid Ctr, Shanghai, Peoples R China
来源
关键词
China; dietary intervention; obesity therapy; real-world evidence; weight control; OBESITY; OVERWEIGHT;
D O I
10.3389/fendo.2024.1470394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To describe weight management and perceptions in China.Materials and methods Data were from the Adelphi Real World Obesity Disease Specific Programme (TM), a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged >= 18 years, under weight management and/or had a body mass index (BMI) >= 28 kg/m2.Results In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI >= 30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).Conclusions These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Association Between Disordered Eating and Weight Loss Outcomes After MBS: A Real-world Study
    Bizimana, Christa
    Sy, Maimouna
    Beltran, Fiona
    Sogg, Stephanie
    OBESITY, 2024, 32 : 56 - 57
  • [42] Real-world Weight Loss Outcomes of Optifast® Total Meal Replacement Program in a Community Clinic
    Naidu, Padmaja
    Lupas, Daniel
    Klas, Alex
    Modi, Mihir
    Naidu, Rishi
    Hamm, Caroline
    OBESITY, 2023, 31 : 252 - 252
  • [43] Weight Loss and Fecundity Among Women with Overweight or Obesity: A Real-World Data Cohort Study
    Verfurden, Maximiliane
    Schnecke, Volker
    Winning-Lehmann, Eva
    Uppal, Shweta
    Sommer, Kasper
    Balen, Adam
    OBESITY, 2023, 31 : 40 - 41
  • [44] Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population
    DerSarkissian, Maral
    Bhak, Rachel H.
    Huang, Joanna
    Buchs, Sarah
    Vekeman, Francis
    Smolarz, B. Gabriel
    Brett, Jason
    Ganguly, Rahul
    Duh, Mei Sheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (06) : 1105 - 1110
  • [45] Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss
    Agnihotri, Abhishek
    Xie, Amy
    Bartalos, Christopher
    Kushnir, Vladimir
    Islam, Sameer
    Islam, Ebtesam
    Lamet, Mark
    Lamet, Ari
    Farboudmanesch, Ramin
    Overholt, Bergein F.
    Altawil, Johnny
    Early, Dayna S.
    Bennett, Michael
    Lowe, Abigail
    Mullady, Daniel K.
    Adeyeri, Christine Sade
    El Zein, Mohamad
    Mishra, Priya
    Fayad, Lea
    Dunlap, Margo
    Oberbach, Andreas
    Cheskin, Lawrence J.
    Kalloo, Anthony N.
    Khashab, Mouen A.
    Kumbhari, Vivek
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (07) : 1081 - +
  • [46] Real-World Vaccine Research and Clinical Practice
    Kumar, Anika
    Acharya, Nisha R.
    JAMA OPHTHALMOLOGY, 2024, 142 (06) : 528 - 529
  • [47] Real-World Clinical Effectiveness of Liraglutide for Weight Management in Türkiye: Insights from the LIRA-TR Study
    Oral, Alihan
    Kucuk, Celalettin
    Kose, Murat
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [48] MANAGEMENT OF TUBEROUS SCLEROSIS COMPLEX IN ENGLAND: INSIGHTS INTO REAL-WORLD CLINICAL PRACTICE
    Kingswood, C.
    Dew, R.
    Gray, E.
    VALUE IN HEALTH, 2015, 18 (03) : A249 - A249
  • [49] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Schaumberg, Debra
    Larholt, Kay
    Apgar, Elizabeth
    Pashos, Chris L.
    Hirsch, Gigi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 472 - 475
  • [50] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Debra Schaumberg
    Kay Larholt
    Elizabeth Apgar
    Chris L. Pashos
    Gigi Hirsch
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 472 - 475